Video: Ethical and regulatory use of biospecimens in the EU
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
List view / Grid view
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
The FDA has released a statement on US Stem Cell Clinic LLC and US Stem Cell Inc's permanent injunction.
New study finds a combination of antibodies that can prepare mice to accept stem cells from an immunologically mismatched donor.
This article outlines the exciting developments that are taking place with immunotherapies and demonstrates how stem-cell technologies are proliferating the paradigm shift in how we tackle cancer treatment.
Thanks to new developments with induced pluripotent stem cells enabling generation of human neurons, scientists can more precisely analyse the effects that chemicals have on human cells. This article describes research into the effects of cannabis on neuronal development and implications of its legalisation in Canada.
Researchers have, for the first time, duplicated a patient's blood-brain barrier (BBB), creating a human BBB chip with stem cells.
A new study shows promise for future neural stem cell therapies in replacing cells lost through disease or injury.
Sartorius Cubis® II is designed to follow US FDA data integrity principles that require data to be accurate, legible, contemporaneous, original and attributable.
This in-depth focus looks at the modification of stem cells to facilitate their efficient delivery to tumours, highlighting the new development of pluripotent stem cells.
In this issue: novel approaches to produce radiolabelled antibodies, the use of CRISPR/Cas9 to accelerate the development of targeted therapies and utilisation of stem cells to study the effects of cannabis on neuronal development.
A novel way to create Expanded Potential Stem Cells has generated opportunities to research regenerative medicine.
Arizona company claims their products can treat Lyme disease, diabetes, Parkinson’s disease and more, but have not been approved for any use.
Researchers use stem cell-based disease models to pinpoint gene linked to impaired memory in Down syndrome.
A new way to cleanly separate out cancer cells from a blood sample will enable comprehensive genetic profiling of the cancer cells.
Integrating hardware, software and fluorescent labels for optimised HCA assay development.